Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroinduced MSCs and Exosomes in Spinocerebellar Palsy
NCT07467733Phase 2Not yet recruiting
- Sponsor
- Biocells Medical
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Modality
- Lipid-based Nanoparticles, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of neuroinduced mesenchymal stem cells, mesenchymal stem cell exosomes in spinocerebellar ataxia (SCA), sponsored by Biocells Medical. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
neuroinduced mesenchymal stem cellsmesenchymal stem cell exosomes
03
Conditions
spinocerebellar ataxia (SCA)
Beyond the preview
Go deeper on NCT07467733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07467733.